Summary of opinion: Ocrevus, 17/09/2026 Positive
Summary of opinion: Ocrevus, 17/09/2026 Positive
Summary of opinion: Ocrevus, 17/09/2026 Positive
Human medicines European public assessment report (EPAR): VaxRabeo, rabies vaccine (inactivated) for human, Status: Opinion
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026
Summary of opinion: Pradaxa, 17/09/2026 Positive
Summary of opinion: Jyseleca Positive
Summary of opinion: Abiraterone Mylan, 17/09/2026 Positive
Benefits of sodium oxybate continue to outweigh risks in people with alcohol dependency
EMA concludes review of ipidacrine-containing medicines
Human medicines European public assessment report (EPAR): Xervyteg, Allogeneic faecal microbiota, pooled, Status: Opinion
Summary of opinion: Tecvayli, 17/09/2026 Positive